OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Wayne Hall, Michael T. Lynskey
World Psychiatry (2020) Vol. 19, Iss. 2, pp. 179-186
Open Access | Times Cited: 232

Showing 1-25 of 232 citing articles:

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 130

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Jakob Manthey, Tom P. Freeman, Carolin Kilian, et al.
The Lancet Regional Health - Europe (2021) Vol. 10, pp. 100227-100227
Open Access | Times Cited: 124

Time to Act on a Growing Public Health Threat—Evidence of Elevated Mortality in Cannabis Use Disorder
Laura J. Bierut, Fang Fang
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457781-e2457781
Open Access | Times Cited: 1

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84

Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Vivian Chiu, Janni Leung, Wayne Hall, et al.
Neuropharmacology (2021) Vol. 193, pp. 108610-108610
Closed Access | Times Cited: 68

Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Deepak Cyril D’Souza, Marta Di Forti, Suhas Ganesh, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 10, pp. 719-742
Closed Access | Times Cited: 62

Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife
Madeline H. Meier, Avshalom Caspi, Annchen R. Knodt, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 5, pp. 362-374
Open Access | Times Cited: 57

Cannabis Vaping Among Youth and Young Adults: a Scoping Review
Melissa B. Harrell, Stephanie L. Clendennen, Aslesha Sumbe, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 3, pp. 217-234
Open Access | Times Cited: 42

Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, et al.
Drug and Alcohol Dependence (2022) Vol. 238, pp. 109582-109582
Closed Access | Times Cited: 42

Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic review
Megan A. O’Grady, Marissa G. Iverson, Adekemi O. Suleiman, et al.
European Child & Adolescent Psychiatry (2022) Vol. 33, Iss. 3, pp. 701-723
Closed Access | Times Cited: 41

Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, et al.
Psychological Medicine (2022) Vol. 53, Iss. 9, pp. 3858-3868
Open Access | Times Cited: 40

Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)
Sameer Imtiaz, Yeshambel T. Nigatu, Farihah Ali, et al.
Drug and Alcohol Dependence (2023) Vol. 244, pp. 109765-109765
Open Access | Times Cited: 38

Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019
Heng Shao, Heyue Du, Quan Gan, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 4, pp. 2485-2507
Open Access | Times Cited: 27

The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review
Jakob Manthey, Britta M. Jacobsen, Tobias Hayer, et al.
International Journal of Drug Policy (2023) Vol. 116, pp. 104039-104039
Closed Access | Times Cited: 24

Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
Benedikt Fischer, Didier Jutras‐Aswad, Wayne Hall
Canadian Medical Association Journal (2023) Vol. 195, Iss. 39, pp. E1351-E1353
Open Access | Times Cited: 22

Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it
Chandni Hindocha, Erin A. McClure
Addiction (2020) Vol. 116, Iss. 7, pp. 1622-1630
Open Access | Times Cited: 57

The why behind the high: determinants of neurocognition during acute cannabis exposure
Johannes G. Ramaekers, Natasha L. Mason, Lilian Kloft, et al.
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 7, pp. 439-454
Closed Access | Times Cited: 54

Association of Recreational Cannabis Legalization With Maternal Cannabis Use in the Preconception, Prenatal, and Postpartum Periods
Kara R. Skelton, Amelie A. Hecht, Sara E. Benjamin‐Neelon
JAMA Network Open (2021) Vol. 4, Iss. 2, pp. e210138-e210138
Open Access | Times Cited: 53

Legalization of cannabis use in Canada: Impacts on the cannabis use profiles of youth seeking services for substance use
Lisa D. Hawke, Joanna Henderson
Journal of Substance Abuse Treatment (2021) Vol. 126, pp. 108340-108340
Open Access | Times Cited: 41

An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
Benedikt Fischer, Angelica Lee, Tessa Robinson, et al.
Substance Abuse Treatment Prevention and Policy (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 41

Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Addictive Behaviors (2023) Vol. 140, pp. 107617-107617
Open Access | Times Cited: 19

The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review
Sara Allaf, Jessy S. Lim, Nicholas A. Buckley, et al.
Addiction (2023) Vol. 118, Iss. 12, pp. 2252-2274
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top